Reduced-intensity conditioning umbilical cord blood transplantation in Nijmegen breakage syndrome

Pediatric Transplantation

Volumn 19, Issue 2, 2015, Pages E51-E55

  Woźniak, Magdalena ^a   Krzywoń, Marta ^a   Hołda, Mateusz K ^a   Goździk, Jolanta ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Nijmegen breakage syndrome; reduced intensity conditioning; severe combined immunodeficiency; stem cell transplantation; umbilical cord blood

Indexed keywords

CYCLOPHOSPHAMIDE; FLUDARABINE; PREDNISONE; THYMOCYTE ANTIBODY;

ARTICLE; CASE REPORT; CHILD; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; GENETIC SCREENING; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; LEUKOCYTOSIS; NIJMEGEN BREAKAGE SYNDROME; NONMYELOABLATIVE CONDITIONING; PATIENT SAFETY; PRESCHOOL CHILD; REDUCED INTENSITY CONDITIONING; TREATMENT DURATION; CHROMOSOME ABERRATION; CYTOLOGY; DONOR; FETUS BLOOD; GENOTYPE; HISTOCOMPATIBILITY; IMMUNE SYSTEM; IMMUNOLOGIC DEFICIENCY SYNDROMES; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; MUTATION; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION;

CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; FETAL BLOOD; GENOTYPE; HUMANS; IMMUNE SYSTEM; IMMUNOLOGIC DEFICIENCY SYNDROMES; MUTATION; NIJMEGEN BREAKAGE SYNDROME; POLYMERASE CHAIN REACTION; TISSUE DONORS; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING;

EID: 84921565965     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/petr.12420     Document Type: Article

References (18)

1. Chrzanowska KH, Gregorek H, Dembowska-Bagińska B, et al. Nijmegen breakage syndrome (NBS). Orphanet J Rare Dis 2012: 7: 13.
2. Chrzanowska K, Dzigweed M, Sperling K, et al. DNA-repair deficiency and cancer: Lessons from lymphoma. In:, Allagayer H, Rehder H, Fulda S, eds. Hereditary Tumors: From Genes to Clinical Consequences. Weinheim: Wiley-VH, 2009: pp. 377-391.
3. Albert MH, Gennery AR, Greil J, et al. Successful SCT for Nijmegen breakage syndrome. Bone Marrow Transplant 2010: 45: 622-626.
4. Ljungman P, Engelhard D, de la Cámara R, et al. Vaccination of stem cell transplant recipients: Recommendations of the Infectious Diseases Working Party of the EBMT. Bone Marrow Transplant 2005: 35: 737-746.
5. Goździk J, Czajka H, Skoczeń S, et al. Bezpieczeństwo i skutecznos̈c szczepień ochronnych prowadzanych u dzieci po przeszczepieniu komõrek krwiotwõrczych. Medycyna wieku rozwojowego 2010: 14: 43-53.
6. EBMT, ESID. EBMT/ESID Guidelines for Haematopoietic Stem Cell Transplantation for Primary Immunodeficiencies. 2011.
7. Piatosa B, Burg M, Siewiera K, et al. The defect in humoral immunity in patients with Nijmegen breakage syndrome is explained by defects in peripheral B lymphocyte maturation. Cytometry A 2012: 81A: 835-842.
8. Bade-Doeding C, Cano P, Huyton T, et al. Mismatches outside exons 2 and 3 do not alter the peptide motif of the allele group B 44:02P. Hum Immunol 2011: 72: 1039-1044.
9. Giralt S, Ballen K, Rizzo D, et al. Reduced-intensity conditioning regimen workshop: Defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. Biol Blood Marrow Transplant 2009: 15: 367-369.
10. Horwitz ME, Chao N,. Non-myeloablative umbilical cord blood transplantation. Best Pract Res Clin Haematol 2010: 23: 231-236.
11. Rizzieri DA, Long GD, Vredenburgh JJ, et al. Successful allogeneic engraftment of mismatched unrelated cord blood following a nonmyeloablative preparative regimen. Blood 2001: 98: 3486-3488.
12. Pulsipher MA, Boucher KM, Wall D, et al. Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: Results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313. Blood 2009: 114: 1429-1436.
13. Parikh SH, Mendizabal A, Benjamin CL, et al. A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases. Biol Blood Marrow Transplant 2014: 20: 326-336.
14. Sawada A, Ohga S, Ishii E, et al. Feasibility of reduced-intensity conditioning followed by unrelated cord blood transplantation for primary hemophagocytic lymphohistiocytosis: A nationwide retrospective analysis in Japan. Int J Hematol 2013: 98: 223-230.
15. Dumas PY, Ruggeri A, Robin M, et al. Incidence and risk factors of EBV reactivation after unrelated cord blood transplantation: A Eurocord and Société Française de Greffe de Moelle-Therapie Cellulaire collaborative study. Bone Marrow Transplant 2013: 48: 253-256.
16. Brunstein CG, Barker JN, Weisdorf DJ, et al. Umbilical cord blood transplantation after nonmyeloablative conditioning: Impact on transplantation outcomes in 110 adults with hematologic disease. Blood 2007: 110: 3064-3070.
17. Uchida N, Wake A, Takagi S, et al. Umbilical cord blood transplantation after reduced-intensity conditioning for elderly patients with hematologic diseases. Biol Blood Marrow Transplant 2008: 14: 583-590.
18. Mohty M, Gaugler B,. Advances in umbilical cord transplantation: The role of thymoglobulin/ATG in cord blood transplantation. Best Pract Res Clin Haematol 2010: 23: 275-282.